The immune modulator FTY720 targets sphingosine 1-phosphate receptors.
about
A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptorSystematic identification of regulatory proteins critical for T-cell activationFingolimod for relapsing-remitting multiple sclerosisFingolimod for relapsing remitting multiple sclerosisSphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast couplingPTEN as an effector in the signaling of antimigratory G protein-coupled receptorOral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trialFTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacologyA defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosisTargeting protein serine/threonine phosphatases for drug developmentA central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egressThe immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptorsThe emerging role of FTY720 (Fingolimod) in cancer treatmentFingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerationsSphingosine 1-phosphate receptor modulators in multiple sclerosisIntegrating the puzzle pieces: the current atomistic picture of phospholipid-G protein coupled receptor interactionsSphingosine-1-phosphate in chronic intestinal inflammation and cancerSphingosine 1-phosphate signallingLysophospholipids and their receptors in the central nervous systemBenefits versus risks of latest therapies in multiple sclerosis: a perspective reviewA review of ceramide analogs as potential anticancer agentsMultiple sclerosis: the role of cytokines in pathogenesis and in therapiesFingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapySphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyondFingolimod for the treatment of neurological diseases-state of play and future perspectivesFTY720 treatment in the convalescence period improves functional recovery and reduces reactive astrogliosis in photothrombotic strokeLysophospholipid receptors in drug discovery.SLI1 (YGR212W) is a major gene conferring resistance to the sphingolipid biosynthesis inhibitor ISP-1, and encodes an ISP-1 N-acetyltransferase in yeastFingolimod Associated Bilateral Cystoid Macular Edema-Wait and See?The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple SclerosisExit Strategies: S1P Signaling and T Cell MigrationSphingosine-1-phosphate suppresses TLR-induced CXCL8 secretion from human T cellsFTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosisDevelopment of oral immunomodulatory agents in the management of multiple sclerosisFTY720 protects cardiac microvessels of diabetes: a critical role of S1P1/3 in diabetic heart diseaseDisparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemiaThe clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in ratFingolimod phosphate attenuates oligomeric amyloid β-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neuronsThe Sphingosine-1-phospate receptor 1 mediates S1P action during cardiac developmentIdentification of sphingolipid metabolites that induce obesity via misregulation of appetite, caloric intake and fat storage in Drosophila
P2860
Q21093656-569BD546-3767-4D87-9135-B39572A362CBQ21245890-E4E06FFB-EB1E-4D84-8A9F-B48E4AEF9123Q24185882-A816C897-D28A-4207-A888-1AEC711DC8D5Q24236597-C80A62B4-2A53-4816-A7A6-DFB5DA5A37F3Q24319108-9C2885FC-5F12-42BF-92F7-BC6284208BCEQ24555751-CAEE1CE1-4775-4466-98E6-6BA8518AAD35Q24564715-01EC1903-2127-49C7-AB93-8CD18AB87019Q24643383-ABB6F384-B8D6-4DD4-9827-623D38FA21A7Q24644684-C66AC04D-80E8-4839-A6EC-92D44AD7B3F9Q24658001-C29CC54F-B3A2-4B87-A039-DB5AA82BECD9Q24679761-AFD62A9E-2C0E-4656-905B-D5F71BC65E1DQ24681206-E66A9C87-983F-4BEC-9FDD-F51ED09C64E9Q26748927-7F4899AB-637C-4A57-B369-6B156E800082Q26765300-EC8DBDA7-7F18-4EBD-93C3-BFD870C08206Q26799440-1732F446-2344-4DC4-A138-0B84618BFACEQ26828893-BCC10DEB-95B4-4A3C-A572-03FCD6178848Q26852824-BF7FF5A3-41C1-4239-BCF0-F79278F42041Q26852942-E272451A-29E4-435F-B22C-E26AB0830B7BQ26859168-B490A094-4548-4297-AA41-49ABAF74ECCDQ26999417-13F60E68-828B-48A0-9CD0-185BC77A7B87Q27009351-5A4D25D7-492B-4C1F-B507-76F85BC88C02Q27011014-A4E50033-7908-4372-B15B-7C9A20527EDFQ27011473-016E3A37-9720-4A5A-B6AA-13DFC86F2DF1Q27011857-6E14E144-5797-4E4F-A5A6-FF3A1B7DF73CQ27026175-43071A3A-0C7C-43CA-B63F-CBF564097383Q27310503-358EDEA2-7E33-40F4-AA2A-D28DA43B01E9Q27692680-94F8A5F9-C77F-453E-A6E6-DCE4DD09C6ECQ27933002-613FBEC9-7604-4035-8E68-B26E5C434EFEQ28068032-ED76DC1A-335B-49F0-A196-B009AA60AF35Q28073377-9C44FFEA-A584-44AC-A46C-7C5F6363E4D9Q28081129-7B18C81D-CE04-442F-89BA-AF0F9E9284F6Q28284022-49A4E494-82B0-40B3-B9F0-9D6FBA1A7324Q28288357-6E07CD07-CD7B-4A6D-8B3E-A9B8F0D11988Q28388704-54C5CDEC-72C4-497D-BC64-4EE36991E6C1Q28482255-347B2FBE-3C54-47FF-9071-D1A3541225E0Q28483245-A36A095E-EB2D-438C-A1C8-E2821F1521DFQ28484640-8AFB6F67-C223-40C0-A1A3-A426BCDD099CQ28486184-6CD15B0D-E030-4A57-97A0-65B431605CAEQ28512659-2DFF74A7-A6F8-48A7-AC10-B211FE0FD85EQ28536054-548FC25D-6AE6-477B-801D-D16851DA6DCD
P2860
The immune modulator FTY720 targets sphingosine 1-phosphate receptors.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
The immune modulator FTY720 targets sphingosine 1-phosphate receptors.
@en
type
label
The immune modulator FTY720 targets sphingosine 1-phosphate receptors.
@en
prefLabel
The immune modulator FTY720 targets sphingosine 1-phosphate receptors.
@en
P2093
P356
P1476
The immune modulator FTY720 targets sphingosine 1-phosphate receptors.
@en
P2093
Carolyn A Foster
Christian Bruns
Christopher E Heise
Eva Prieschl
Kevin R Lynch
Markus Zollinger
Michael D Davis
Peter Hiestand
Rainer Albert
Robert Hof
P304
21453-21457
P356
10.1074/JBC.C200176200
P407
P577
2002-04-19T00:00:00Z